Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured b…
Amneal Pharmaceuticals of New York, LLC · Defective Delivery System: Possibility of no medication in the prefilled pen.
- Status
- Ongoing
- City
- Brookhaven
- State
- NY
- Country
- United States
- Classification
- Class II
- Product type
- Drugs
- Event ID
- 99762
- Recalling firm
- Amneal Pharmaceuticals of New York, LLC
- Address 1
- 50 Horseblock Rd
- Postal code
- 11719-9509
- Voluntary mandated
- Voluntary: Firm initiated
- Initial firm notification
- Letter
- Distribution pattern
- USA Nationwide
- Recall number
- D-0868-2026
- Product quantity
- 5,694 pens
- Reason for recall
- Defective Delivery System: Possibility of no medication in the prefilled pen.
- Recall initiation date
- 20260828
- Center classification date
- 20260922
- Report date
- 20260930
- Code info
- Lot #: AP250095A, Exp 2/28/2027
- Product description
Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213, India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1685-1
- Harmonized identifiers (openFDA)
- Application number
- ANDA206697
- Brand name
- EXENATIDE
- Generic name
- EXENATIDE
- Manufacturer name
- Amneal Pharmaceuticals LLC
- Product NDC
- 70121-1685, 70121-1686
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- SUBCUTANEOUS
- Substance name
- EXENATIDE
- RxCUI
- 847910, 847915
- SPL ID
- 2141c3ca-074a-4098-85da-1ef78ec4d4dc
- SPL set ID
- e6cb5c8f-e97f-4a6a-95a4-939fd2393949
- Package NDC
- 70121-1685-1, 70121-1686-1
- Is original packager
- true
- Nui
- N0000178480, M0160181, N0000020058
- Pharm class epc
- GLP-1 Receptor Agonist [EPC]
- Pharm class cs
- Glucagon-Like Peptide 1 [CS]
- Pharm class moa
- Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
- UNII
- 9P1872D4OL
